LIN SUE-JEAN bought ARQT
November 24, 2025 · Form 4 insider transaction
LIN SUE-JEAN bought 18,052 shares of Arcutis Biotherapeutics, Inc. at $8.63 per share, a transaction worth $155.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
18,052
Price
$8.63
Total value
$155.8K
InsiderLIN SUE-JEAN
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 24, 2025
Filing dateNovember 25, 2025
Shares owned after44,787
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 14, 2024, subject to the non-employee director's continuous service.